---
figid: PMC11566422__12967_2024_5847_Fig2_HTML
figtitle: ENO1 and its targeted therapy in tumors
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11566422
filename: 12967_2024_5847_Fig2_HTML.jpg
figlink: /pmc/articles/PMC11566422/figure/FNA/
number: F2
caption: Fig. 2. ENO1 promotes chemoresistance in tumors by promoting glycolysis [14]
  and activating the PI3K/AKT [106], YAP1 [30], and Wnt/β-catenin signaling pathways
  [107]. ENOblock, an inhibitor of ENO1, blocks this chemoresistant effect by inhibiting
  ENO1 [58, 106]
papertitle: Role of ENO1 and its targeted therapy in tumors
reftext: Yafei Li, et al. J Transl Med. 2024;22(NA).
year: '2024'
doi: 10.1186/s12967-024-05847-8
journal_title: Journal of Translational Medicine
journal_nlm_ta: J Transl Med
publisher_name: BMC
keywords: ''
automl_pathway: 0.9490386
figid_alias: PMC11566422__F2
figtype: Figure
redirect_from: /figures/PMC11566422__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11566422__12967_2024_5847_Fig2_HTML.html
  '@type': Dataset
  description: Fig. 2. ENO1 promotes chemoresistance in tumors by promoting glycolysis
    [14] and activating the PI3K/AKT [106], YAP1 [30], and Wnt/β-catenin signaling
    pathways [107]. ENOblock, an inhibitor of ENO1, blocks this chemoresistant effect
    by inhibiting ENO1 [58, 106]
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - YAP1
  - TAFAZZIN
  - WWTR1
  - AKT1
  - AKT2
  - AKT3
  - ENO1
  - WDTC1
  - ATP8A2
  - GSK3A
  - GSK3B
  - CTNNB1
  - HNF4A
  - SOX2
  - CD44
  - CCND1
  - MMP7
  - MYC
  - ADP
  - Pyruvate
  - ATP
  - Lactate
---
